Immuno - Oncoloy: A New Class Of Drugs
AUAUniversity10 Okt 2018

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal Antibodies" and "Checkpoint Inhibitors". CME Available: https://auau.auanet.org/node/21336

Avsnitt(423)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Sta...

1 Nov 201844min

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Okt 201837min

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Okt 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Okt 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Okt 201830min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Okt 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Okt 201829min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
nu-blir-det-historia
harrisons-dramatiska-historia
rss-viktmedicinpodden
johannes-hansen-podcast
sektledare
not-fanny-anymore
roda-vita-rosen
rss-sjalsligt-avkladd
i-vantan-pa-katastrofen
allt-du-velat-veta
sa-in-i-sjalen
rss-beratta-alltid-det-har
alska-oss
rss-max-tant-med-max-villman
rikatillsammans-om-privatekonomi-rikedom-i-livet
sektpodden
dumforklarat